Los Angeles Capital Management’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-67,751	Closed	-$192K	–	2462
2025 Q4	$192K	Buy	67,751 +19,579	+41%	+$63.3K	﹤0.01%	1251
2025 Q3	$128K	Hold	48,172	–	–	﹤0.01%	1311
2025 Q2	$47.4K	Hold	48,172	–	–	﹤0.01%	1308
2025 Q1	$69.4K	Buy	+48,172	New	+$88.8K	﹤0.01%	1070
2021 Q2	–	Sell	-18,005	Closed	-$505K	–	1576
2021 Q1	$505K	Sell	18,005 -13,062	-42%	-$385K	﹤0.01%	1213
2020 Q4	$808K	Sell	31,067 -25	-0.1%	-$749	﹤0.01%	1026
2020 Q3	$1.16M	Hold	31,092	–	–	0.01%	768
2020 Q2	$1.59M	Sell	31,092 -225	-0.7%	-$9.41K	0.01%	684
2020 Q1	$987K	Sell	31,317 -9,068	-22%	-$479K	0.01%	712
2019 Q4	$2.41M	Sell	40,385 -6,305	-14%	-$283K	0.01%	596
2019 Q3	$1.71M	Buy	46,690 +19,170	+70%	+$759K	0.01%	671
2019 Q2	$1.28M	Buy	+27,520	New	+$1.29M	0.01%	763
2018 Q2	–	Sell	-3,160	Closed	-$229K	–	1448
2018 Q1	$229K	Buy	+3,160	New	+$232K	﹤0.01%	1236